Cargando…
Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
INTRODUCTION: Patients with early-onset Alzheimer's disease (EOAD) experience seizures and subclinical epileptiform activity, which may accelerate cognitive and functional decline. Antiseizure medicines (ASMs) may be a tractable disease-modifying strategy; numerous ASMs are marketed with well-e...
Autores principales: | Lehmann, Leanne M., Barker-Haliski, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427874/ https://www.ncbi.nlm.nih.gov/pubmed/37592944 http://dx.doi.org/10.3389/fneur.2023.1223472 |
Ejemplares similares
-
Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
por: Vande Vyver, Maxime, et al.
Publicado: (2022) -
Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures
por: Zierath, Dannielle, et al.
Publicado: (2023) -
Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy
por: del Pozo, Aaron, et al.
Publicado: (2022) -
Epidemiology and injectable antiseizure medication treatment patterns of seizure patients treated in United States hospitals
por: Beaty, Silky, et al.
Publicado: (2022) -
Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
por: Lehmann, Leanne, et al.
Publicado: (2021)